were recruited from a neurological clinic (342 patients) covering Arhus and east central Jutland, a headache research unit in a university hospital (60 patients), and from a department of neurology (19 patients) both covering Copenhagen County. A detailed semistructured headache history was taken by neurologists or neurological residents trained in headache diagnoses. All probands had a physical and a neurological examination to exclude other medical or neurological disorders. The probands received a mailed questionnaire. If the first questionnaire evoked no response, a second was mailed. The questionnaire response rate was 88% (370/421). The probands were asked about the number and sex of their first and second degree relatives, the age of their first degree relatives, and if any of their relatives had ever experienced cluster headache. Probands with a positive family history were interviewed by telephone (MBR). Subsequently, all possibly affected relatives were interviewed by telephone. Only relatives fulfilling the cluster headache criteria of the IHS had the diagnosis. The probands and the closest family members were interviewed about possibly affected dead relatives. A diagnosis of cluster headache was accepted only if this second hand history confirmed the diagnosis according to the criteria of the IHS, with the exception of criteria C, which specifies that headache is associated with at least one of the following signs on the pain side: conjunctival injection, lacrimation, nasal congestion, rhinorrhoea, forehead and facial sweating, miosis, ptosis, or eyelid oedema.
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STATISTICAL ANALYSES
The complex segregation analysis is based on the distribution of the disease in nuclear families (parents and their offspring). Each pedigree ascertained on the basis of the probands can contain one or more nuclear families. The 370 cluster headache probands belonged to 366 pedigrees, which were split into 691 nuclear families with 1915 children. The characteristics of the major dominant locus for cluster headache by liability class is shown in table 4. The penetrance (probability for disease given the genotype, P(disease gentoype)) was almost the same in the males (liability classes 1-4), being 0-34 in the heterozygote or homozygote for the highest incidence group. The penetrance in females (liability classes 5-8) was slightly lower than found in males, being 0-21 in the heterozygote or homozygote for the highest incidence group. This means that after the age of 40 years, male heterozygote or homozygote carriers have a 34% risk and female heterozygote or homozygote carriers have a 21% risk of cluster headache. The gene is responsible for the disease in only a minority of those with cluster headache (probability for genotype given disease, P(genotype disease)). However, the gene is more often responsible for the disease in females than males, and more often in those below the age of 20.
Discussion
The increased familial risk of cluster headache strongly suggests that the disease has a genetic cause.4 5 The complex segregation analysis with a pointer8 supported the importance of a genetic factor, since the multifactorial model (H>0) gave a significantly better fit than the sporadic model (H = 0). The segregation analysis suggested that an autosomal dominant gene is present in a minority of those with cluster headache. This was not statistically significant with a 5% level of significance (p<0 10), but it was the model which gave the best fit. The results indicate that the gene is twice as frequent in females with cluster headache as in males.
The penetrance was estimated to be approximately 1-5-fold higher among males than females. This can only explain a fraction of the overall male preponderance of cluster headache. We did not use transmission probabilities (r2) in the analysis, since it has been shown not to be correctly implemented in POINTER. 9 We conclude that cluster headache is at least partly the result of an autosomal dominant gene with a penetrance of 0-30-0 34 in males and 0 17-0-21 in females. The gene is present in 3-4% of males and 7-10% of females with cluster headache. Future research should be directed toward identification of the cluster headache gene by linkage analysis in order to confirm the above result.
